http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 14 Oct 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+Peptide+ETF+%28PEPT%29/27183883.html <p class="bwalignc"> <i>New thematic ETF targets the full peptide value chain: the drug developers, manufacturers, delivery specialists, and consumer brands behind today’s GLP-1 treatments and the pipeline forming beyond obesity, in one globally diversified trade.</i> </p> <p> MIAMI--(BUSINESS WIRE)-- REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX Peptide ETF (Ticker: PEPT), a thematic ETF built to own the peptide economy end to end. PEPT holds the companies that develop, manufacture, deliver, and commercialize peptide-based products, expanding investor exposure beyond the two drugmakers that dominate today’s GLP-1 market. It is REX’s third thematic ETF, http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+Peptide+ETF+%28PEPT%29/27183883.html Wed, 14 Oct 2026 08:00:00 -0400 PEPT http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+Peptide+ETF+%28PEPT%29/27183883.html <p class="bwalignc"> <i>New thematic ETF targets the full peptide value chain: the drug developers, manufacturers, delivery specialists, and consumer brands behind today’s GLP-1 treatments and the pipeline forming beyond obesity, in one globally diversified trade.</i> </p> <p> MIAMI--(BUSINESS WIRE)-- REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX Peptide ETF (Ticker: PEPT), a thematic ETF built to own the peptide economy end to end. PEPT holds the companies that develop, manufacture, deliver, and commercialize peptide-based products, expanding investor exposure beyond the two drugmakers that dominate today’s GLP-1 market. It is REX’s third thematic ETF, http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+Peptide+ETF+%28PEPT%29/27183883.html Wed, 14 Oct 2026 08:00:00 -0400 PEPT